Morgan Stanley raised target for Amplifon stock from EUR 14.90 to EUR 14.96

Published on 10/15/2026 at 10:28 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Amplifon posted 4.7 percent organic growth in Q2 2026. Amplifon stock costs EUR 12.24 on October 15, 2026 within its EUR 7.84-15.84 range.

Analyst view and operating progress

Morgan Stanley raised its target from EUR 14.90 to EUR 14.96 on October 9, 2026.
Amplifon's second-quarter organic growth reached 4.7 percent in 2026.
Amplifon stock trades at EUR 12.24 at 10:15 a.m. CEST at Lang & Schwarz on October 15, 2026.

Flatlay mit Aktienzertifikat, ISIN-Karte und kleinem Hörgerät auf Holztisch — Flatlay-Arrangement mit Aktienzertifikat und Hörgerät illustriert Investment in Amplifon S.p.A., ISIN IT0004056880, dem Hörgeräte-Marktführer, Illustration mit AI erstellt.

Amplifon (ISIN IT0004056880) was trading at EUR 12.24 at Lang & Schwarz on October 15, 2026 at 10:15 a.m. CEST. The hearing-care group remained the subject of a Morgan Stanley target increase to EUR 14.96 from EUR 14.90 on October 9, 2026, according to Teleborsa.

What does Q2 mean for margins?

Amplifon's second-quarter 2026 revenue reached EUR 606 million, up 1.7 percent at constant exchange rates from the prior year. Adjusted EBITDA came to EUR 156 million, while the adjusted EBITDA margin rose to 25.8 percent, 90 basis points above the second quarter of 2025, according to the Yahoo Finance transcript.

The first-half 2026 figures show the same operating pattern. Revenue increased 1.3 percent at constant exchange rates, adjusted EBITDA reached EUR 298 million, and adjusted free cash flow rose to EUR 68 million from EUR 40 million in the first half of 2025. Management kept its objective of organic revenue growth above 3 percent and an adjusted EBITDA margin improvement of about 100 basis points for fiscal year 2026, as discussed in the same transcript.

Three dated steps since September

On September 17, 2026, Amplifon's board approved a partial demerger by way of a spin-off, according to the company's corporate release. On September 29, 2026, the company called a shareholders' meeting for October 29, 2026, as stated in another Amplifon notice. The latest step came on October 9, 2026, when Morgan Stanley lifted its target by EUR 0.06 while retaining its Overweight recommendation, according to Teleborsa.

Upcoming dates on October 29

The next two scheduled dates are October 29, 2026, for Amplifon's third-quarter and nine-month results, and October 29, 2026, for the shareholders' meeting. The results date is also identified in recent market coverage, while the meeting date appears in the company's notice.

Stock valuation remains central

Amplifon trades within a EUR 7.84 to EUR 15.84 52-week range and carries a market capitalization of EUR 2.7 billion as of October 15, 2026. Its target revision is modest, so the October 29 results will provide the next quantified test of whether stronger organic growth is translating into sustained margin gains.

Amplifon was trading at EUR 12.24 at Lang & Schwarz on October 15, 2026 at 10:15 a.m. CEST. The further course of trading is shown by the continuously updated real-time quote of Amplifon stock.